Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials
October 16 -- A Chinese drugmaker with military ties has sent an experimental Ebola drug to Africa for use by Chinese aid workers and is planning clinical trials there to combat a deadly outbreak of the disease, executives at the firm told Reuters on Thursday.
Sihuan Pharmaceutical Holdings Group Ltd has supplied several thousand doses of its drug JK-05 to the region, Chief Operating Officer Jia Zhongxin said. More doses could be sent if needed, Jia said.
An Ebola outbreak in West Africa, the worst on record, has killed more than 4,000 people.
Sihuan Pharmaceutical Holdings Group Ltd has supplied several thousand doses of its drug JK-05 to the region, Chief Operating Officer Jia Zhongxin said. More doses could be sent if needed, Jia said.
An Ebola outbreak in West Africa, the worst on record, has killed more than 4,000 people.